Hair Relaxer Lawsuit Lawyer – MDL 3060

For decades, millions of women — particularly Black women — have used chemical hair relaxers and straightening products as part of their regular hair care routines. These products, marketed as safe and effective by some of the world’s largest personal care companies, contain a cocktail of endocrine-disrupting chemicals that scientific research has now linked to an increased risk of serious cancers, including uterine cancer, ovarian cancer, endometrial cancer, and uterine fibroids.

A landmark 2022 study published by the National Institutes of Health (NIH), using data from the Sister Study cohort of nearly 34,000 women, found that women who frequently used chemical hair straightening products had a more than doubled risk of developing uterine cancer compared to women who did not use these products. This finding, combined with decades of earlier research linking endocrine-disrupting chemicals to hormone-sensitive cancers, has triggered a massive wave of litigation against the manufacturers of these products.

The cases have been consolidated into a multidistrict litigation (MDL) proceeding — In Re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation, MDL No. 3060 — pending in the United States District Court for the Northern District of Illinois before Judge Mary M. Rowland.

At Wetherington Law Firm, our mass tort attorneys are representing women across Georgia and nationwide who have been diagnosed with cancer or other serious conditions after years of using chemical hair relaxers. We understand the deeply personal nature of these cases and the disproportionate impact this crisis has had on the Black community. Our firm is committed to holding these manufacturers accountable for knowingly selling dangerous products.

The Science: How Hair Relaxers Cause Cancer

Chemical hair relaxers work by breaking the disulfide bonds in curly or kinky hair, permanently altering the hair’s structure to make it straight. This process requires powerful chemicals that are absorbed through the scalp during application. The scalp is a highly permeable area of skin with rich blood supply, making it an efficient route for chemical absorption into the bloodstream.

Endocrine-Disrupting Chemicals in Hair Relaxers

Research has identified numerous endocrine-disrupting chemicals (EDCs) in chemical hair relaxer products, including:

• Phthalates: Used as plasticizers and fragrance carriers. Phthalates are potent endocrine disruptors that can mimic or interfere with estrogen and other hormones. Studies have detected elevated phthalate levels in the blood and urine of women who use hair relaxers.
• Formaldehyde and formaldehyde-releasing agents: Used as preservatives and straightening agents. Formaldehyde is classified by IARC as a Group 1 carcinogen. Many “formaldehyde-free” products contain chemicals like methylene glycol that release formaldehyde when heated during the straightening process.
• Parabens: Preservatives with estrogenic activity. Parabens can bind to estrogen receptors and stimulate the growth of estrogen-sensitive tissues, including the uterine lining.
• Bisphenol A (BPA): An industrial chemical with strong estrogenic properties. BPA has been detected in hair care products and has been linked to reproductive cancers.
• Cyclosiloxanes: Used as conditioning agents. Some cyclosiloxanes have demonstrated estrogenic and anti-androgenic activity in laboratory studies.
• Di(2-ethylhexyl) phthalate (DEHP): A particular phthalate compound that has been found at elevated levels in hair relaxer users and is classified as a probable human carcinogen.

The Mechanism: Endocrine Disruption and Cancer

The endocrine system regulates virtually every biological process in the body through hormones, including estrogen, progesterone, and testosterone. Estrogen plays a critical role in the development and maintenance of the female reproductive system, including the uterus, ovaries, and breasts. When endocrine-disrupting chemicals mimic estrogen or interfere with normal hormonal signaling, they can:

• Stimulate abnormal cell proliferation in estrogen-sensitive tissues
• Promote the development of uterine fibroids (estrogen-dependent benign tumors)
• Increase the risk of endometrial hyperplasia (thickening of the uterine lining that can become cancerous)
• Interfere with DNA repair mechanisms, allowing mutations to accumulate
• Disrupt the normal cell death process (apoptosis), allowing damaged cells to survive and proliferate

Because hair relaxers are used repeatedly over many years — often starting in childhood or adolescence — the cumulative exposure to these endocrine disruptors can be substantial. The NIH Sister Study found a clear dose-response relationship: the more frequently women used hair straighteners, the higher their risk of uterine cancer.

Key Scientific Studies

Several major studies have established the connection between chemical hair relaxer use and cancer:

• NIH Sister Study (Chang et al., 2022): Published in the Journal of the National Cancer Institute, this study followed 33,497 women ages 35-74 for an average of 10.9 years. Women who reported using chemical hair straightening products more than four times in the previous year had a 2.55 times higher risk of uterine cancer compared to non-users. This was the first large-scale prospective study to specifically link hair straighteners to uterine cancer.
• NIH Sister Study (White et al., 2021): A separate analysis of the same cohort found that frequent use of chemical hair straighteners was associated with a 30% increased risk of breast cancer.
• Black Women’s Health Study: This long-running study of more than 50,000 Black women found elevated rates of uterine fibroids among women who used chemical hair relaxers, with risk increasing with duration and frequency of use.
• Llanos et al. (2020): Found that use of chemical hair products, including relaxers, was associated with earlier onset of breast cancer among Black women.
• Onyije et al. (2022): An analysis published in Environmental Research found that hair product chemicals were associated with increased risk of ovarian cancer and uterine cancer.

The Disproportionate Impact on Black Women

The hair relaxer cancer crisis is inextricably linked to race. The personal care products industry has aggressively marketed chemical hair relaxers and straighteners to Black women and girls for decades. Cultural pressures around hair texture and European beauty standards have driven widespread adoption of these products in the Black community.

The Disparities

• Usage rates: Studies estimate that approximately 80-90% of Black women have used chemical hair relaxers at some point in their lives, compared to approximately 10% of white women.
• Age of first use: Many Black girls begin using chemical hair relaxers in childhood, some as young as 5-8 years old. Early exposure during critical developmental periods may compound the health risks.
• Frequency of use: Regular users typically apply hair relaxers every 6-8 weeks, resulting in decades of repeated chemical exposure.
• Uterine cancer disparities: Black women have higher rates of uterine cancer mortality than white women, and the gap has been widening over recent decades. While multiple factors contribute to this disparity, the disproportionate exposure to EDCs through hair care products is now recognized as a significant contributing factor.
• Uterine fibroid disparities: Black women are 2-3 times more likely to develop uterine fibroids than white women, a disparity that researchers have linked in part to chemical exposures from hair care products.

Environmental Justice and Corporate Accountability

A central allegation in the hair relaxer litigation is that manufacturers knew or should have known about the health risks of their products but continued to market them aggressively, particularly to communities of color. The lawsuit alleges that companies failed to adequately test their products for long-term health effects, failed to warn consumers about the risks of endocrine-disrupting chemicals, continued marketing to communities they knew would be disproportionately harmed, and lobbied against regulatory oversight of personal care product ingredients.

This case represents a critical environmental justice issue. The communities most harmed by these products are the same communities that face systemic barriers to healthcare access, early cancer screening, and legal representation. Our firm is committed to ensuring that these communities have access to the legal system and the compensation they deserve.

Current Status of the Hair Relaxer MDL (MDL 3060)

The hair relaxer litigation has moved rapidly since the first lawsuits were filed in late 2022:

Timeline of Key Developments

• October 2022: First hair relaxer cancer lawsuits filed following publication of the NIH Sister Study.
• February 2023: The Judicial Panel on Multidistrict Litigation (JPML) consolidates all federal hair relaxer lawsuits into MDL No. 3060 in the Northern District of Illinois, assigned to Judge Mary M. Rowland.
• 2023: Defendants file motions to dismiss; plaintiffs file consolidated master complaints. Discovery begins.
• 2024: Bellwether case selection process begins. The court establishes a trial track and selects representative cases for early trial to help establish precedent and valuation.
• 2024-2025: Expert discovery, including Daubert challenges to scientific and medical experts. The admissibility of causation evidence is a central battleground.
• 2025: The litigation continues to grow as more women are diagnosed and file claims. As of early 2025, thousands of cases are pending in the MDL.

Named Defendants

The MDL names numerous manufacturers, distributors, and retailers of chemical hair relaxer products as defendants, including:

• L’Oréal USA, Inc. — maker of Dark and Lovely, Soft Sheen-Carson products
• Revlon, Inc. — maker of Revlon Relaxer and related products (note: Revlon filed for bankruptcy in 2022, which complicates but does not eliminate claims)
• Namaste Laboratories LLC — maker of ORS (Organic Root Stimulator) products
• Strength of Nature LLC — maker of African Pride and Just for Me products
• Dabur International Ltd. — parent company of Namaste Laboratories
• Godrej Consumer Products
• Various retailers that marketed and sold these products

What to Expect Going Forward

Mass tort MDL litigation of this scale typically follows a predictable trajectory: early procedural motions and discovery, followed by bellwether trials that establish case values and create pressure for global settlement. The ultimate resolution — whether through individual trials, global settlement, or a combination — will likely take several years. We provide regular case updates to all our clients and ensure they understand the process at every stage.

Eligibility: Who Can File a Hair Relaxer Lawsuit?

To potentially qualify for a hair relaxer lawsuit, you generally must meet the following criteria:

Primary Eligibility Requirements

1. Product use: You must have regularly used chemical hair relaxer or straightening products for a sustained period, typically at least two or more years.
2. Qualifying diagnosis: You must have been diagnosed with a qualifying medical condition, including:
   • Uterine cancer (endometrial cancer)
   • Ovarian cancer
   • Uterine fibroids (particularly if fibroids required surgical intervention such as hysterectomy or myomectomy)
   • Endometriosis
   • Breast cancer (in some cases, depending on product use history and timing)
3. Temporal relationship: Your diagnosis must have occurred during or after a period of significant product use, with a biologically plausible latency period between exposure and diagnosis.

Factors That Strengthen a Claim

• Duration of use: The longer you used chemical hair relaxers, the stronger the association with cancer risk. Women who used these products for 10 or more years typically have stronger claims.
• Frequency of use: More frequent use (e.g., every 4-8 weeks) strengthens the dose-response relationship.
• Age at first use: Beginning use in childhood or adolescence, during critical developmental periods, may strengthen causation arguments.
• Product identification: Being able to identify specific products and brands used strengthens the claim against specific manufacturers.
• Absence of alternative risk factors: If you have no significant family history of the diagnosed cancer and no other major risk factors, the case for causation is stronger.

Who May Not Qualify

Not every person who used hair relaxers and later developed cancer will have a viable claim. Factors that may weigh against a claim include:

• Very infrequent or short-duration product use
• Diagnosis that occurred many decades before substantial product use
• Strong alternative causation (e.g., known genetic predisposition like BRCA mutations for breast/ovarian cancer)
• Conditions not currently recognized as linked to hair relaxer chemicals

Our attorneys evaluate each case individually and provide honest assessments of claim viability. We do not accept cases we do not believe we can successfully pursue.

Georgia-Specific Filing Considerations

While hair relaxer cases are consolidated in the federal MDL in Illinois, Georgia-specific legal considerations still matter:

Georgia Statute of Limitations

Georgia’s general personal injury statute of limitations is two years from the date of injury under O.C.G.A. § 9-3-33. For product liability claims, the statute typically begins to run when the plaintiff knew or should have known of the connection between the product and the injury (the “discovery rule”). In mass tort cases involving latent diseases, this can be a complex analysis.

Under O.C.G.A. § 51-1-11, Georgia recognizes strict product liability claims for defective products that are unreasonably dangerous. Georgia also allows claims based on failure to warn (inadequate warnings about known risks), design defect, manufacturing defect, negligence, and breach of implied warranty of merchantability.

Georgia’s Product Liability Statute of Repose

Georgia has a 10-year statute of repose for product liability claims under O.C.G.A. § 51-1-11(b)(2), which bars claims brought more than 10 years after the first sale of the product. However, for products that are used repeatedly over many years (like hair relaxers), each purchase may restart the repose period. Additionally, ongoing exposure may extend the accrual date. This is a nuanced legal analysis that varies by individual circumstances.

Georgia Comparative Negligence

Georgia follows a modified comparative negligence rule under O.C.G.A. § 51-12-33. A plaintiff can recover damages as long as they are less than 50% at fault. However, in hair relaxer cases, comparative negligence is unlikely to be a significant factor because consumers used these products as directed and had no way of knowing about the hidden cancer risks. Manufacturers cannot shift blame to consumers for using products as marketed.

Types of Compensation in Hair Relaxer Lawsuits

If your hair relaxer case is successful, you may be entitled to compensation for:

• Medical expenses: All past, present, and future costs of treating your cancer or other condition, including surgery, chemotherapy, radiation therapy, immunotherapy, hormone therapy, hospitalization, follow-up care, and palliative care
• Lost income: Wages and earning capacity lost due to your illness and treatment
• Pain and suffering: Physical pain, emotional distress, anxiety, depression, and diminished quality of life
• Loss of reproductive capacity: If your condition required hysterectomy, oophorectomy, or otherwise affected your fertility
• Disfigurement: Surgical scars and physical changes resulting from treatment
• Loss of consortium: Impact on your relationship with your spouse or partner
• Wrongful death: If a loved one died from a hair relaxer-related cancer, surviving family members may recover funeral and burial costs, loss of financial support, and loss of companionship
• Punitive damages: If manufacturers are found to have acted with willful disregard for consumer safety, punitive damages may be available under O.C.G.A. § 51-12-5.1

The Filing Process: How Hair Relaxer Claims Work

Filing a hair relaxer claim involves a structured process that our attorneys manage on your behalf:

Step 1: Case Evaluation

Our attorneys begin with a thorough evaluation of your case, reviewing your product use history (brands, frequency, duration, and age at first use), your medical records and diagnosis, your family medical history and other potential risk factors, and the strength of the causal connection between your product use and your condition. This initial evaluation is free and confidential.

Step 2: Filing in the MDL

If your case meets the eligibility criteria, we file your individual complaint and it is transferred to the MDL in the Northern District of Illinois. While your case is consolidated with others for pretrial proceedings, it remains your individual case with your specific facts and damages.

Step 3: Discovery and Evidence Development

During the discovery phase, both sides exchange evidence. In an MDL, much of the discovery is coordinated across all cases, which is more efficient than conducting discovery separately in thousands of individual cases. This includes document production from manufacturers, deposition testimony from corporate representatives and experts, scientific and medical expert reports, and individual plaintiff fact sheets documenting each claimant’s use history and injuries.

Step 4: Resolution

Cases in the MDL may be resolved through bellwether trial verdicts (which set valuation benchmarks), individual settlements negotiated based on case-specific facts, or a global settlement agreement that provides a framework for resolving all or most claims. Our attorneys advocate for the best possible outcome for each individual client throughout this process.

Why Choose Wetherington Law Firm

Our firm brings specific strengths to hair relaxer cases:

• Georgia roots with national reach: Based in Atlanta, we serve the large Georgia community affected by hair relaxer products while participating in the national MDL litigation.
• Mass tort experience: Our attorneys understand the unique procedural, scientific, and strategic demands of multidistrict litigation.
• Client-centered approach: We treat every client as an individual, not a case number. We take the time to understand your story, your product use history, and your medical journey.
• No upfront costs: We handle hair relaxer cases on a contingency fee basis. You pay nothing unless we recover compensation for you.
• Bilingual services: We serve clients in both English and Spanish.

Frequently Asked Questions About the Hair Relaxer Lawsuit

Which specific products are involved in the hair relaxer lawsuits?

The lawsuits target chemical hair relaxer and straightening products from multiple brands, including Dark and Lovely, Just for Me, ORS (Organic Root Stimulator), African Pride, Motions, TCB Naturals, Soft & Beautiful, Optimum Care, and Revlon Relaxer products, among others. Any chemical hair relaxer or straightening product containing endocrine-disrupting chemicals may be implicated. If you are unsure whether your specific product is included, contact our office for guidance.

I used hair relaxers for years but have not been diagnosed with cancer. Should I be concerned?

If you have used chemical hair relaxers for an extended period, we recommend discussing your exposure history with your healthcare provider. Regular screening for uterine, ovarian, and breast cancer is important. At this time, you cannot file a lawsuit without a qualifying diagnosis, but being proactive about your health is essential. If you are later diagnosed, you should contact an attorney promptly.

How much compensation can I expect from a hair relaxer lawsuit?

It is too early in the litigation to predict specific compensation amounts. Individual case values depend on factors including the severity of the diagnosis, the extent of treatment required, the impact on your life and livelihood, and the strength of causation evidence. We do not make promises about specific dollar amounts. As bellwether trials proceed and any settlement framework develops, we will provide our clients with updated assessments.

How long will the hair relaxer lawsuit take?

Mass tort MDL litigation typically takes several years from consolidation to resolution. The hair relaxer MDL was consolidated in February 2023, and bellwether trials are being scheduled. A global settlement, if one is reached, could take additional time to negotiate and distribute. We keep all clients informed of progress and significant developments throughout the process.

Can I still file a hair relaxer lawsuit in 2026?

Potentially, yes. The statute of limitations varies by state and by when you were diagnosed or became aware of the connection between hair relaxers and your condition. Georgia’s two-year statute of limitations may apply, but the discovery rule can extend the filing deadline. Contact our office as soon as possible so we can evaluate your specific timeline. Waiting too long risks losing your right to file.

I used “natural” or “organic” hair relaxers. Are those included?

Many products marketed as “natural” or “organic” still contain endocrine-disrupting chemicals. Marketing claims on personal care products are not regulated as strictly as pharmaceutical claims. If your “natural” product was a chemical relaxer or straightener (i.e., it permanently altered your hair structure), it likely contains the same types of chemicals at issue in the litigation. Contact our office so we can evaluate your specific products.

Do I need to have receipts or product packaging to file a claim?

While having product packaging, receipts, or other documentation is helpful, it is not strictly required. Most people do not keep receipts for hair care products purchased years ago. Your testimony about which products you used, how often, and for how long is important evidence. Photographs showing your hair routine, salon records, and testimony from family members or stylists can also help establish your product use history.

Will filing a lawsuit affect my current medical care?

No. Filing a lawsuit will not affect your insurance coverage, your VA benefits, or your access to medical care. Your medical records will be relevant to the lawsuit, but your healthcare providers will continue to treat you as normal. You should always prioritize your health and follow your doctors’ recommendations regardless of the legal process.

Related Practice Areas

• Mass Tort Litigation
• Wrongful Death Lawyer
• Medical Malpractice Lawyer
• Camp Lejeune Water Contamination Lawyer